News

Yahoo Finance1mon
Kite Presents New Real-World Data Supporting Use of Potentially Curative Yescarta® in Outpatient Care Setting for Patients with Relapsed/Refractory Large B-Cell Lymphoma at ...
SANTA MONICA, Calif., June 01, 2025--Kite, a Gilead Company (Nasdaq: GILD), today announced real-world data evaluating the safety and effectiveness of Yescarta® (axicabtagene ciloleucel) for ...
KXAN1mon
Kiteworks and Kite Distribution Form Strategic Alliance to Enhance Private Data Exchange in the UK Market - KXAN Austin
This strategic partnership with Kite Distribution represents an important milestone in our mission to help UK organisations secure their most sensitive data exchanges.” — David Byrnes, VP of ...
Business Wire1mon
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel ...
At EHA, Kite and its partner Arcellx will present updated findings from the Phase 2 registrational iMMagine-1 study of anitocabtagene-autoleucel (anito-cel) in relapsed/refractory multiple myeloma ...
Morningstar1mon
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data ... - Morningstar
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T ...
Nasdaq1mon
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From ... - Nasdaq
FOSTER CITY, Calif.& SANTA MONICA, Calif.---- Gilead Sciences, Inc. will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology ...
Yahoo Finance1mon
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel ...
FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society ...
Yahoo Finance1mon
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel ...
FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of ...
Financial Post1mon
Aptose Selected for Prestigious Oral Presentation of Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the ... - Financial Post
Details of the presentation are as follows: Title: TUSCANY Study of Safety and Efficacy of Tuspetinib Plus Standard of Care Venetoclax and Azacitidine in Study Participants with Newly Diagnosed AML ...
Morningstar3mon
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025 - Morningstar
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to ...
PharmiWeb4mon
KITE PRESENTS NEW DATA ON PATIENT OUTCOMES WITH CAR T-CELL THERAPY AT THE 7TH EUROPEAN CAR T-CELL MEETING, 6-8 FEBRUARY, STRASBOURG, FRANCE - PharmiWeb.com
Stockley Park, UK – 6 February 2025 – Kite, a Gilead Company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell ...
Investing6mon
Kite AI Partners with GAIB to Create AI Marketplace for Open Data and GPU Power By Chainwire - Investing.com
Kite AI Partners with GAIB to Create AI Marketplace for Open Data and GPU Power Cryptocurrency Published 12/16/2024, 09:05 AM Updated 12/16/2024, 09:30 AM ...